达标：美国最新预防服务工作组前列腺癌筛查建议。
Making the grade: The newest US Preventive Services Task Force prostate cancer screening recommendation.
机构信息
Department of Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa.
Cancer Epidemiology and Population Science, University of Iowa Holden Comprehensive Cancer Center, Iowa City, Iowa.
出版信息
Cancer. 2017 Oct 15;123(20):3875-3878. doi: 10.1002/cncr.30941. Epub 2017 Aug 22.
Abstract
The USPSTF recently issued a draft guideline supporting individualized decision making for prostate cancer screening. While we believe this guideline appropriately reflects changing evidence on the benefits and harms of screening, we raise concerns about achieving decision making, interpreting active surveillance data, and initiating screening for African American men.
摘要
USPSTF 最近发布了一份支持前列腺癌筛查个体化决策的指南草案。虽然我们认为该指南恰当地反映了筛查的获益和危害方面不断变化的证据，但我们对实现决策制定、解读主动监测数据以及为非裔美国男性启动筛查提出了担忧。
相似文献
1
Making the grade: The newest US Preventive Services Task Force prostate cancer screening recommendation.达标：美国最新预防服务工作组前列腺癌筛查建议。
Cancer. 2017 Oct 15;123(20):3875-3878. doi: 10.1002/cncr.30941. Epub 2017 Aug 22.
2
Prostate Cancer Screening.前列腺癌筛查
Med Clin North Am. 2018 Mar;102(2):199-214. doi: 10.1016/j.mcna.2017.11.001.
3
Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging.美国预防服务工作组“D”级推荐对前列腺癌筛查及分期的影响
Curr Opin Urol. 2017 May;27(3):205-209. doi: 10.1097/MOU.0000000000000383.
4
The politics of prostate cancer screening.前列腺癌筛查的政治。
Urol Clin North Am. 2014 May;41(2):249-55. doi: 10.1016/j.ucl.2014.01.004. Epub 2014 Feb 19.
5
Re: National Prostate Cancer Screening Rates after the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.关于：2012年美国预防服务工作组建议不鼓励基于前列腺特异性抗原的筛查后美国的前列腺癌筛查率。
J Urol. 2016 Feb;195(2):350-1. doi: 10.1016/j.juro.2015.10.166. Epub 2015 Nov 4.
6
Testing and referral patterns in the years surrounding the US Preventive Services Task Force recommendation against prostate-specific antigen screening.围绕美国预防服务工作组关于反对前列腺特异性抗原筛查建议的那些年里的检测和转诊模式。
Cancer. 2016 Dec 15;122(24):3785-3793. doi: 10.1002/cncr.30330. Epub 2016 Sep 22.
7
Decline in Prostate Cancer Screening by Primary Care Physicians: An Analysis of Trends in the Use of Digital Rectal Examination and Prostate Specific Antigen Testing.初级保健医生中前列腺癌筛查的下降：数字直肠检查和前列腺特异性抗原检测使用趋势分析。
J Urol. 2016 Oct;196(4):1047-52. doi: 10.1016/j.juro.2016.03.171. Epub 2016 Apr 6.
8
Trends in Prostate Cancer Screening Following Changes Made by the US Preventive Services Task Force: Are We Turning Back the Clock?美国预防服务工作组做出改变后前列腺癌筛查的趋势：我们在开倒车吗？
JAMA Surg. 2017 Feb 1;152(2):198. doi: 10.1001/jamasurg.2016.3999.
9
Words of wisdom: Re: Screening for prostate cancer: US Preventive Services Task Force recommendation statement.智慧之言：关于：前列腺癌筛查：美国预防服务工作组建议声明。
Eur Urol. 2013 Sep;64(3):512. doi: 10.1016/j.eururo.2013.06.027.
10
Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement.前列腺癌筛查：美国预防服务工作组推荐声明。
Ann Intern Med. 2012 Jul 17;157(2):120-34. doi: 10.7326/0003-4819-157-2-201207170-00459.
引用本文的文献
1
Association between Liver Fibrosis and Serum PSA among U.S. Men: National Health and Nutrition Examination Survey (NHANES), 2001-2010.美国男性肝纤维化与血清 PSA 之间的关系：国家健康和营养调查（NHANES），2001-2010 年。
Cancer Epidemiol Biomarkers Prev. 2019 Aug;28(8):1331-1338. doi: 10.1158/1055-9965.EPI-19-0145. Epub 2019 Jun 3.
本文引用的文献
1
Decision aids for people facing health treatment or screening decisions.为面临医疗治疗或筛查决策的人们提供的决策辅助工具。
Cochrane Database Syst Rev. 2017 Apr 12;4(4):CD001431. doi: 10.1002/14651858.CD001431.pub5.
2
Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.三个州的前列腺癌筛查决策：2013年行为危险因素监测系统分析
Cancer Causes Control. 2017 Mar;28(3):235-240. doi: 10.1007/s10552-017-0860-8. Epub 2017 Feb 16.
3
10-Year Outcomes in Localized Prostate Cancer.局限性前列腺癌的10年预后
N Engl J Med. 2017 Jan 12;376(2):178. doi: 10.1056/NEJMc1614342.
4
Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States.美国前列腺癌诊断时远处转移的增加。
JAMA Oncol. 2017 May 1;3(5):705-707. doi: 10.1001/jamaoncol.2016.5465.
5
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.PLCO试验中前列腺癌筛查的延长死亡率结果，中位随访时间为15年。
Cancer. 2017 Feb 15;123(4):592-599. doi: 10.1002/cncr.30474. Epub 2016 Dec 1.
6
10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer.局限性前列腺癌监测、手术或放疗 10 年后的结果。
N Engl J Med. 2016 Oct 13;375(15):1415-1424. doi: 10.1056/NEJMoa1606220. Epub 2016 Sep 14.
7
Prostate Cancer, Version 1.2016.前列腺癌临床实践指南（2016 年版）
J Natl Compr Canc Netw. 2016 Jan;14(1):19-30. doi: 10.6004/jnccn.2016.0004.
8
Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations.与 USPSTF 筛查建议相关的前列腺癌发病率和 PSA 检测模式。
JAMA. 2015 Nov 17;314(19):2054-61. doi: 10.1001/jama.2015.14905.
9
Trends in Management for Patients With Localized Prostate Cancer, 1990-2013.1990 - 2013年局限性前列腺癌患者的管理趋势
JAMA. 2015 Jul 7;314(1):80-2. doi: 10.1001/jama.2015.6036.
10
Assessing the effectiveness of decision aids for decision making in prostate cancer testing: a systematic review.评估决策辅助工具在前列腺癌检测决策中的有效性：一项系统综述。
Psychooncology. 2015 Oct;24(10):1303-1315. doi: 10.1002/pon.3815. Epub 2015 Apr 15.
Zotero 插件